EdgarLookup

REINSURANCE GROUP OF AMERICA INC — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that REINSURANCE GROUP OF AMERICA INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
17.8%
Profit Margin
Net income ÷ revenue
0.8%
Return on Assets
Net income ÷ assets
10.63x
Debt-to-Equity
Total liabilities ÷ equity
+6.9%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $6.64B Feb 20, 2026
FY2025 Sep 30, 2025 $6.20B Feb 20, 2026
FY2025 Jun 30, 2025 $5.60B Feb 20, 2026
FY2025 Mar 31, 2025 $5.26B Feb 20, 2026
FY2025 Dec 31, 2024 $5.24B Feb 20, 2026
FY2025 Sep 30, 2024 $5.65B Feb 20, 2026
FY2025 Jun 30, 2024 $4.88B Feb 20, 2026
FY2025 Mar 31, 2024 $6.34B Feb 20, 2026
FY2024 Dec 31, 2023 $5.01B Feb 21, 2025
FY2024 Sep 30, 2023 $5.15B Feb 21, 2025

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.18B Feb 20, 2026
FY2025 Dec 31, 2024 $717.00M Feb 20, 2026
FY2025 Dec 31, 2023 $902.00M Feb 20, 2026
FY2024 Dec 31, 2022 $517.00M Feb 21, 2025
FY2021 Dec 31, 2021 $156.00M Feb 25, 2022
FY2021 Sep 30, 2021 ($22.00M) Feb 25, 2022
FY2021 Jun 30, 2021 $344.00M Feb 25, 2022
FY2021 Mar 31, 2021 $139.00M Feb 25, 2022
FY2021 Dec 31, 2020 $132.00M Feb 25, 2022
FY2021 Sep 30, 2020 $213.00M Feb 25, 2022

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.09B Feb 20, 2026
FY2025 Dec 31, 2024 $9.37B Feb 20, 2026
FY2025 Dec 31, 2023 $4.04B Feb 20, 2026
FY2024 Dec 31, 2022 $1.34B Feb 21, 2025
FY2023 Dec 31, 2021 $4.18B Feb 26, 2024
FY2022 Dec 31, 2020 $3.32B Feb 24, 2023
FY2021 Dec 31, 2019 $2.31B Feb 25, 2022
FY2020 Dec 31, 2018 $1.58B Feb 26, 2021
FY2019 Dec 31, 2017 $1.98B Feb 27, 2020
FY2018 Dec 31, 2016 $1.47B Feb 27, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2022 $25.00M Feb 24, 2023
FY2022 Dec 31, 2021 $19.00M Feb 24, 2023
FY2022 Dec 31, 2020 $28.00M Feb 24, 2023
FY2021 Dec 31, 2019 $34.00M Feb 25, 2022
FY2020 Dec 31, 2018 $29.00M Feb 26, 2021
FY2019 Dec 31, 2017 $44.00M Feb 27, 2020
FY2018 Dec 31, 2016 $44.64M Feb 27, 2019
FY2017 Dec 31, 2015 $23.55M Feb 27, 2018
FY2016 Dec 31, 2014 $88.36M Feb 28, 2017
FY2015 Dec 31, 2013 $0 Feb 29, 2016

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $156.59B Feb 20, 2026
FY2025 Dec 31, 2024 $118.68B Feb 20, 2026
FY2024 Dec 31, 2023 $97.62B Feb 21, 2025
FY2024 Dec 31, 2022 $84.90B Feb 21, 2025
FY2023 Dec 31, 2021 $92.94B Feb 26, 2024
FY2021 Dec 31, 2020 $84.66B Feb 25, 2022
FY2020 Dec 31, 2019 $76.73B Feb 26, 2021
FY2019 Dec 31, 2018 $64.54B Feb 27, 2020
FY2018 Dec 31, 2017 $60.51B Feb 27, 2019
FY2017 Dec 31, 2016 $53.10B Feb 27, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $143.04B Feb 20, 2026
FY2025 Dec 31, 2024 $107.77B Feb 20, 2026
FY2024 Dec 31, 2023 $88.45B Feb 21, 2025
FY2023 Dec 31, 2022 $77.73B Feb 26, 2024
FY2022 Dec 31, 2021 $79.16B Feb 24, 2023
FY2021 Dec 31, 2020 $70.30B Feb 25, 2022
FY2020 Dec 31, 2019 $65.13B Feb 26, 2021
FY2019 Dec 31, 2018 $56.09B Feb 27, 2020
FY2018 Dec 31, 2017 $50.95B Feb 27, 2019
FY2017 Dec 31, 2016 $46.00B Feb 27, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $13.46B Feb 20, 2026
FY2025 Dec 31, 2024 $10.82B Feb 20, 2026
FY2025 Dec 31, 2023 $9.08B Feb 20, 2026
FY2025 Dec 31, 2022 $7.08B Feb 20, 2026
FY2024 Dec 31, 2021 $8.18B Feb 21, 2025
FY2022 Dec 31, 2020 $14.35B Feb 24, 2023
FY2022 Dec 31, 2019 $11.60B Feb 24, 2023
FY2021 Dec 31, 2018 $8.45B Feb 25, 2022
FY2020 Dec 31, 2017 $9.57B Feb 26, 2021
FY2019 Dec 31, 2016 $7.09B Feb 27, 2020

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2022 $7.00M Feb 24, 2023
FY2022 Dec 31, 2021 $7.00M Feb 24, 2023
FY2021 Dec 31, 2020 $7.00M Feb 25, 2022
FY2019 Dec 31, 2019 $7.00M Feb 27, 2020
FY2019 Dec 31, 2018 $7.00M Feb 27, 2020
FY2018 Dec 31, 2017 $7.00M Feb 27, 2019
FY2017 Dec 31, 2016 $7.00M Feb 27, 2018
FY2016 Dec 31, 2015 $7.00M Feb 28, 2017
FY2015 Dec 31, 2014 $7.00M Feb 29, 2016
FY2014 Dec 31, 2013 $7.00M Mar 2, 2015

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $10.15B Feb 20, 2026
FY2025 Dec 31, 2024 $9.26B Feb 20, 2026
FY2024 Dec 31, 2023 $8.81B Feb 21, 2025
FY2023 Dec 31, 2022 $8.17B Feb 26, 2024
FY2022 Dec 31, 2021 $8.56B Feb 24, 2023
FY2021 Dec 31, 2020 $8.15B Feb 25, 2022
FY2020 Dec 31, 2019 $7.95B Feb 26, 2021
FY2019 Dec 31, 2018 $7.29B Feb 27, 2020
FY2018 Dec 31, 2017 $6.74B Feb 27, 2019
FY2017 Dec 31, 2016 $5.20B Feb 27, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.17B Feb 20, 2026
FY2025 Dec 31, 2024 $3.33B Feb 20, 2026
FY2025 Dec 31, 2023 $2.97B Feb 20, 2026
FY2024 Dec 31, 2022 $2.93B Feb 21, 2025
FY2025 Dec 31, 2021 $2.93B Feb 20, 2026
FY2024 Dec 31, 2020 $2.95B Feb 21, 2025
FY2023 Dec 31, 2019 $3.41B Feb 26, 2024
FY2022 Dec 31, 2018 $1.45B Feb 24, 2023
FY2020 Dec 31, 2017 $1.30B Feb 26, 2021
FY2019 Dec 31, 2016 $1.20B Feb 27, 2020

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.71B Feb 20, 2026
FY2025 Dec 31, 2024 $5.04B Feb 20, 2026
FY2024 Dec 31, 2023 $4.43B Feb 21, 2025
FY2023 Dec 31, 2022 $3.96B Feb 26, 2024
FY2022 Dec 31, 2021 $3.67B Feb 24, 2023
FY2021 Dec 31, 2020 $3.57B Feb 25, 2022
FY2020 Dec 31, 2019 $2.98B Feb 26, 2021
FY2019 Dec 31, 2018 $2.79B Feb 27, 2020
FY2018 Dec 31, 2017 $2.79B Feb 27, 2019
FY2017 Dec 31, 2016 $3.09B Feb 27, 2018

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 7 Feb 20, 2026
FY2025 Sep 30, 2025 3 Feb 20, 2026
FY2025 Jun 30, 2025 2 Feb 20, 2026
FY2025 Mar 31, 2025 4 Feb 20, 2026
FY2025 Dec 31, 2024 2 Feb 20, 2026
FY2025 Sep 30, 2024 2 Feb 20, 2026
FY2025 Jun 30, 2024 3 Feb 20, 2026
FY2025 Mar 31, 2024 3 Feb 20, 2026
FY2024 Dec 31, 2023 2 Feb 21, 2025
FY2024 Sep 30, 2023 4 Feb 21, 2025

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 6 Feb 20, 2026
FY2025 Sep 30, 2025 3 Feb 20, 2026
FY2025 Jun 30, 2025 2 Feb 20, 2026
FY2025 Mar 31, 2025 4 Feb 20, 2026
FY2025 Dec 31, 2024 2 Feb 20, 2026
FY2025 Sep 30, 2024 2 Feb 20, 2026
FY2025 Jun 30, 2024 3 Feb 20, 2026
FY2025 Mar 31, 2024 3 Feb 20, 2026
FY2024 Dec 31, 2023 2 Feb 21, 2025
FY2024 Sep 30, 2023 4 Feb 21, 2025

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2019 Dec 31, 2019 62.66M Feb 27, 2020
FY2019 Dec 31, 2018 62.81M Feb 27, 2020
FY2018 Dec 31, 2017 64.45M Feb 27, 2019
FY2017 Dec 31, 2016 64.30M Feb 27, 2018
FY2016 Dec 31, 2015 65.20M Feb 28, 2017
FY2015 Dec 31, 2014 68.77M Feb 29, 2016
FY2014 Dec 31, 2013 70.77M Mar 2, 2015
FY2013 Sep 30, 2013 70.54M Feb 27, 2014
FY2013 Jun 30, 2013 70.97M Feb 27, 2014
FY2013 Mar 31, 2013 73.30M Feb 27, 2014